Journal
LEUKEMIA & LYMPHOMA
Volume 61, Issue 1, Pages 146-155Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/10428194.2019.1654095
Keywords
Hematologic malignancies; days at home; palliative care; end of life; health services research
Categories
Funding
- Cancer Care Ontario (CCO) through Ontario Ministry of Health and Long-Term Care (MOHLTC)
- ICES - Ontario MOHLTC
- Roy and Marjorie Linden Fund
- Joan Fisher and James Rowland Fund
Ask authors/readers for more resources
Despite advances in the management of hematologic malignancies, a significant proportion of patients die of their disease. We used administrative databases in Ontario, Canada (between 2005 and 2013) to determine the number of days spent at home in the last 6 months of life. We studied the predictors of the median number of days at home (DAH) using quantile regression. For the 11,127 patients with hematologic malignancies who died, the median number of DAH in the last 6 months was 156 days. Patients with acute leukemias (p < .0001), women (p < .0001), and those requiring transfusions (p < .0001) spent the fewest DAH. Patients assessed by palliative care prior to their last 6 months were likely to spend more time at home (p < .0001). Providing additional supports for patients nearing the end of life, including earlier access to palliative care and continued transfusion support, may increase the likelihood that patients can die at home.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available